285 related articles for article (PubMed ID: 32304160)
1. Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.
Li Y; Wang J; Yu Y; Qiu C; Li Z; Ling Q; Zhang G; Li L; Gong Y; Lu Q; Cao L; Gu T; Wang X; Zhang M; Zhang Q; Zhang H; Xu B; Shao L; Pu Y; Zhang W
Liver Int; 2020 Oct; 40(10):2377-2384. PubMed ID: 32304160
[TBL] [Abstract][Full Text] [Related]
2. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
3. Incidence of mother-to-child transmission of hepatitis B in relation to maternal peripartum antiviral prophylaxis: A systematic review and meta-analysis.
Yao N; Fu S; Wu Y; Tian Z; Feng Y; Li J; Luo X; Yang Y; Ji F; Chen Y; Liu J; Zhao Y; Chen T
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1197-1206. PubMed ID: 36082797
[TBL] [Abstract][Full Text] [Related]
4. Telbivudine prevents vertical transmission of hepatitis B virus from women with high viral loads: a prospective long-term study.
Wu Q; Huang H; Sun X; Pan M; He Y; Tan S; Zeng Y; Li L; Deng G; Yan Z; He D; Li J; Wang Y
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1170-6. PubMed ID: 25251571
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis.
Liu CP; Zeng YL; Zhou M; Chen LL; Hu R; Wang L; Tang H
Intern Med; 2015; 54(7):711-6. PubMed ID: 25832930
[TBL] [Abstract][Full Text] [Related]
6. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
Zhang L; Gui XE; Teter C; Zhong H; Pang Z; Ding L; Li F; Zhou Y; Zhang L
Vaccine; 2014 Oct; 32(46):6091-7. PubMed ID: 25240752
[TBL] [Abstract][Full Text] [Related]
7. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
[TBL] [Abstract][Full Text] [Related]
8. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
[TBL] [Abstract][Full Text] [Related]
9. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
Pan CQ; Duan Z; Dai E; Zhang S; Han G; Wang Y; Zhang H; Zou H; Zhu B; Zhao W; Jiang H;
N Engl J Med; 2016 Jun; 374(24):2324-34. PubMed ID: 27305192
[TBL] [Abstract][Full Text] [Related]
10. Tenofovir disoproxil fumarate therapy to prevent hepatitis B virus vertical transmission-A review of maternal and infant outcomes.
Samadi Kochaksaraei G; Shaheen AA; Seow CH; Barkema HW; Coffin CS
Liver Int; 2022 Aug; 42(8):1712-1730. PubMed ID: 35312156
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis.
Boucheron P; Lu Y; Yoshida K; Zhao T; Funk AL; Lunel-Fabiani F; Guingané A; Tuaillon E; van Holten J; Chou R; Bulterys M; Shimakawa Y
Lancet Infect Dis; 2021 Jan; 21(1):85-96. PubMed ID: 32805201
[TBL] [Abstract][Full Text] [Related]
13. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
; Dionne-Odom J; Tita AT; Silverman NS
Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
[TBL] [Abstract][Full Text] [Related]
14. Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.
Huang H; Xu C; Liu L; Chen L; Zhu X; Chen J; Feng J; Chen T; Xu B; Yang J; Xu B; Pan M; Dai Y; Hu Y; Zhou YH
Clin Infect Dis; 2021 Nov; 73(9):e3317-e3323. PubMed ID: 32634824
[TBL] [Abstract][Full Text] [Related]
15. [Identification of risk factors related to the failure of immunization to interrupt hepatitis B virus perinatal transmission].
Yin YZ; Zhou J; Zhang PZ; Hou HY
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):105-10. PubMed ID: 23663881
[TBL] [Abstract][Full Text] [Related]
16. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
18. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of tenofovir alafenamide fumarate for preventing mother-to-child transmission of hepatitis B virus: a national cohort study.
Ding Y; Cao L; Zhu L; Huang Y; Lin C; Wang Y; Liu Y; Sheng Q; Wang S; Fan J; Chen R; Gan W; Chen B; Pan CQ
Aliment Pharmacol Ther; 2020 Oct; 52(8):1377-1386. PubMed ID: 32852100
[TBL] [Abstract][Full Text] [Related]
20. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
